| Income Statement |
| Total Revenue | 1.00B |
|
| Revenues (USD) | 1.00B |
| Cost of Revenue | 792.20M |
| Gross Profit | 211.86M |
| Operating Expenses | 102.80M |
| Research and Development Expense | 7.98M |
| Selling, General and Administrative Expense | 87.60M |
| Operating Income | 109.06M |
| Interest Expense | 10.50M |
| Income Tax Expense | -1.80M |
| Net Income | 83.05M |
| Net Income Common Stock | 83.05M |
| Net Income Common Stock (USD) | 83.05M |
| Consolidated Income | 83.05M |
| Earnings per Basic Share | 0.80 |
| Earnings per Basic Share (USD) | 0.80 |
| Earnings per Diluted Share | 0.77 |
| Earning Before Interest & Taxes (EBIT) | 91.74M |
| Earning Before Interest & Taxes (USD) | 91.74M |
| Weighted Average Shares | 103.85M |
| Balance Sheet |
| Cash and Equivalents | 507.91M |
| Cash and Equivalents (USD) | 507.91M |
| Trade and Non-Trade Receivables | 720.14M |
| Current Assets | 2.25B |
| Property, Plant & Equipment Net | 1.29B |
| Total Assets | 4.42B |
| Debt Current | 4.00M |
| Total Debt | 1.08B |
| Current Liabilities | 1.26B |
| Debt Non-Current | 1.07B |
| Total Liabilities | 2.48B |
| Accumulated Retained Earnings (Deficit) | 1.15B |
| Accumulated Other Comprehensive Income | -29.44M |
| Shareholders Equity | 1.93B |
| Shareholders Equity (USD) | 1.93B |
| Assets Non-Current | 2.17B |
| Total Debt (USD) | 1.08B |
| Deferred Revenue | 186.77M |
| Goodwill and Intangible Assets | 806.61M |
| Inventory | 307.97M |
| Liabilities Non-Current | 1.22B |
| Trade and Non-Trade Payables | 812.99M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 31.12M |
| Net Cash Flow from Financing | 51.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 97.86M |
| Capital Expenditure | -50.42M |
| Issuance (Repayment) of Debt Securities | 52.03M |
| Net Cash Flow from Investing | -50.42M |
| Net Cash Flow from Operations | 96.43M |
| Effect of Exchange Rate Changes on Cash | 88.00K |
| Share Based Compensation | 13.29M |